Further Explanation on Early, Accurate, Fast, and Non-invasive.

Early


The CARDx ECD (patented 12-lead CCG) has the ability to detect patients suffering from early asymptomatic stages of CAD. With twice as many patients experiencing their first acute myocardial infarction during the early stages of the disease, this system is a breakthrough technology for preventative cardiac care.

Accurate


Evidence has shown the 12-lead CCG performance is excellent in detecting and differentiating abnormalities of cardiac conditions. At present, the diagnostic accuracy of the system yields up to 94%. These capabilities surpass the accuracy that current diagnostic tools can deliver. Please refer to comparative analysis for details.

Fast


Taking only 10-minutes, this truly stress-free test can be performed at any point-of-care setting. At the end of the test, the CARDx ECD system generates a detailed report in PDF format within seconds. This system is built with the following user benefits in mind:

1. Ease of use
2. Intuitive features
3. Short learning curve

Non-invasive


The clinical setup is the same as the conventionally resting ECG (EKG) test, which attaches 10 electrodes to the patient for simultaneous analysis on 12-lead CCG and ECG.